Cleveland BioLabs (CBLI) Surged To A New High On Entolimod News

Cleveland BioLabs (CBLI) announced Monday morning that the European Medicines Agency has accepted its pediatric investigation plan for entolimod as a medical radiation countermeasure.

from RTT - Before the Bell http://ift.tt/2oI4vRU
via IFTTT